Conference
C-reactive protein as a prognostic factor in advanced urothelial carcinoma receiving chemotherapy or immunotherapy.
Abstract
436
Background: Clinical prognostic factors have been reported for patients receiving systemic chemotherapy. We hypothesized that markers of tissue damage and inflammation may be prognostic. We conducted a retrospective study to evaluate the prognostic impact of serum lactate dehydrogenase (LDH) and C-reactive protein (CRP) in patients with metastatic UC. Methods: We collected data for patients with metastatic UC receiving …
Authors
Zhao Y; Pond GR; Naik G; Wei XX; McGregor BA; Sonpavde G
Volume
36
Pagination
pp. 436-436
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
February 20, 2018
DOI
10.1200/jco.2018.36.6_suppl.436
Conference proceedings
Journal of Clinical Oncology
Issue
6_suppl
ISSN
0732-183X